A detailed history of Slocum, Gordon & CO LLP transactions in Perkinelmer Inc stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 559,239 shares of PKI stock, worth $67.7 Million. This represents 13.22% of its overall portfolio holdings.

Number of Shares
559,239
Previous 2,760 20162.28%
Holding current value
$67.7 Million
Previous $333,000 20220.42%
% of portfolio
13.22%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
N/A
556,479 Added 20162.28%
559,239 $67.7 Million
Q1 2024

May 02, 2024

SELL
N/A
-190 Reduced 6.44%
2,760 $333,000
Q2 2023

Oct 23, 2023

BUY
$0.0 - $137.11 $0 - $404,474
2,950 New
2,950 $0

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.